References
- Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents, Volumes I to VIII. IARC Cancer Base No. 7, Lyon, France (2005).
- Arcangeli G, Strigari L, Arcangeli S et al. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys.75(4), 975–982 (2009).
- Zelefsky MJ, Eastham JA, Cronin AM et al. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J. Clin. Oncol.28(9), 1508–1513 (2010).
- Abdel-Wahab M, Reis IM, Wu J, Duncan R. Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data. Urology74(4), 866–871 (2009).
- Ghoneim MA, Abol-Enein H. Management of muscle-invasive bladder cancer: an update. Nat. Clin. Pract. Urol.5(9), 501–508 (2008).
- Ghoneim MA, Abdel-Latif M, el-Mekresh M et al. Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J. Urol.180(1), 121–127 (2008).
- Zaghloul MS. Adjuvant and neoadjuvant radiotherapy for bladder cancer: revisited. Future Oncol.6(7), 1177–1191 (2010).
- Zaghloul MS, Mousa AG. Trimodality treatment for bladder cancer: does modern radiotherapy improve the end results? Expert Rev. Anticancer Ther.10(12), 1933–1944 (2010).
- Advanced Bladder Cancer (ABC) Metaanalysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: an update of systematic review and meta-analysis of individual patient data. Europ. Urol.48, 202–206 (2005).
- Kurokawa K, Ito K, Yamamoto T et al. Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer. Urology63(2), 268–272 (2004).
- Saad M, Abdel-Rahim M, Abol-Enein H, Ghoneim MA. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review. BJU Int.102(11), 1544–1550 (2008).